Results 161 to 170 of about 152,878 (197)
Some of the next articles are maybe not open access.

Sublingual immunotherapy in children

Expert Opinion on Biological Therapy, 2008
Sublingual immunotherapy (SLIT) is a safe and patient-friendly variant of allergen immunotherapy. These characteristics may provide physicians with a therapy, perfectly suited to the treatment of allergic children. To give an overview of currently published studies on SLIT in children Pubmed was searched for randomised clinical trials (RCTs).
openaire   +3 more sources

Sublingual specific immunotherapy.

Discovery medicine, 2010
Sublingual application of allergen extracts in specific immunotherapy is a modern approach aimed at improving patient treatment acceptance through reduced serious side effects. This therapeutic approach has proven to be efficacious and safe for the treatment of allergies caused by airborne allergens: 1) studies have shown a rapid onset of action, as ...
Mösges R., El Hassan E., Passali D.
openaire   +2 more sources

Sublingual immunotherapy: The optimism and the issues

Journal of Allergy and Clinical Immunology, 2007
The acceptability of sublingual immunotherapy (SLIT) in guidelines or statements has recently increased. SLIT is currently used in Europe, Asia, and Australia for the treatment of allergic respiratory diseases. Four meta-analyses have shown that SLIT is an effective tool for the treatment of patients with asthma and/or rhinitis, and only conflicting ...
openaire   +2 more sources

Sublingual immunotherapy: A comprehensive review

Journal of Allergy and Clinical Immunology, 2006
Sublingual immunotherapy (SLIT) has been used with increasing frequency in Europe and is viewed with increasing interest by allergists in the United States. To address this interest, a Joint Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology's Immunotherapy and Allergy ...
Linda S, Cox   +5 more
openaire   +2 more sources

Sublingual immunotherapy in children

Current Opinion in Allergy & Clinical Immunology, 2014
Sublingual immunotherapy (SLIT) is indicated for the use in pediatric patients suffering from allergic rhinitis or allergic rhinoconjunctivitis caused by environmental allergens, such as ragweed pollen, grass pollen, and dust mite. This review focuses on recent and relevant studies associated with the use of SLIT for these allergens in children by ...
Nicole, Pleskovic   +2 more
openaire   +2 more sources

Sublingual immunotherapy of allergic diseases

Expert Opinion on Drug Delivery, 2006
The only disease-modifying treatment that is available for allergic patients is allergen-specific immunotherapy. Two competing application forms are used: subcutaneous immunotherapy, which has been used for > 90 years, and a relatively new immunotherapy where the allergen is applied sublingually.
Melanie, Werner-Klein   +2 more
openaire   +2 more sources

Emerging sublingual immunotherapy drugs

Expert Opinion on Pharmacotherapy, 2010
There is epidemiological evidence that respiratory allergy has reached epidemic proportions; owing to the related socio-economic impact, this topic deserves particular attention. An integrated approach involving pharmacotherapy and the immunomodulatory effect of immunotherapy is expected to optimize the management of respiratory allergy, reducing its ...
Compalati E   +4 more
openaire   +3 more sources

Sublingual immunotherapy: update 2006

Current Opinion in Allergy & Clinical Immunology, 2006
Sublingual immunotherapy is currently accepted as a viable therapeutic option, and is widely used in many European countries. In the past 2 years, new data concerning clinical, immunological and practical aspects of sublingual immunotherapy have been published, and many critical points have been addressed.In addition to the new data on clinical ...
PASSALACQUA, GIOVANNI, CANONICA, GIORGIO
openaire   +3 more sources

Sublingual immunotherapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2006
Lucie, Heinzerling   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy